Hansa Biopharma AB (HNSA.ST) Q3 2024 Earnings

18JulConfirmed
Q3 2023
Q4 2023
Q1 2024
Q3 2024
-3.6
-3.32
-3.04
-2.76

Details

Expected EPS
-2.764588253233347
Actual EPS
-3.2812723053
Surprise EPS
-0.52
Surprise Percent
+18.69%

Description

Hansa Biopharma AB (HNSA.ST) has reported earnings of -3.2812723053 per share for Q3 2024.

0 Comments

Share your thoughts